科技广药丨白云山敬修堂首个PCT国际专利在澳获得授权

广药白云山
Dec 06, 2025

近日,广药集团旗下白云山敬修堂自主研发的首个PCT国际专利“USE OF COMPOSITION COMPRISING ASTILBIN AND/OR ISOMER THEREOF IN PREPARATION OF DRUG FOR TREATING PSORIASIS”(一种包含落新妇苷和/或其异构体的组合物在制备治疗银屑病的药物中的用途)正式获得澳大利亚专利局授权。这标志着白云山敬修堂在全球...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10